Fingerprint
Dive into the research topics where Nathan J Cherrington is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
ORGANIC PHASE IMMUNOASSAY FOR CHLORINATED DIBENZODIOXINS
Cherrington, N. J. (PI) & Bignami, G. S. (PI)
6/1/92 → …
Project: Research project
-
-
-
-
-
Alterations of valsartan pharmacokinetics in a rodent model of metabolic dysfunction–associated steatohepatitis
Farrera, D. O., Alaaldin, M. M., Lindberg, P., Sample, P. A., Lenzen-Hammerel, P., LaMadrid, C. S., Haymore, R., Wright, S. H. & Cherrington, N. J., Mar 2025, In: Drug Metabolism and Disposition. 53, 3, 100043.Research output: Contribution to journal › Article › peer-review
Open Access -
Computational Approaches for Predicting Drug Interactions with Human Organic Anion Transporter 4 (OAT4)
Martinez-Guerrero, L., Vignaux, P. A., Harris, J. S., Lane, T. R., Urbina, F., Wright, S. H., Ekins, S. & Cherrington, N. J., Apr 7 2025, In: Molecular Pharmaceutics. 22, 4, p. 1847-1858 12 p.Research output: Contribution to journal › Article › peer-review
4 Link opens in a new tab Scopus citations -
Experimental and computational approaches for evaluating molecule interactions with equilibrative nucleoside transporters 1 and 2
Martinez-Guerrero, L. J., Vignaux, P. A., Farrera, D. O., Harris, J. S., Raman, R., Lane, T. R., Wright, S. H., Ekins, S. & Cherrington, N. J., Sep 2025, In: Journal of Pharmacology and Experimental Therapeutics. 392, 9, 103660.Research output: Contribution to journal › Article › peer-review
Open Access1 Link opens in a new tab Scopus citations -
Inhibition of equilibrative nucleoside transporters 1 and 2 by proteolysis-targeting chimeras (PROTACs)
Vignaux, P. A., Martinez Guerrero, L. J., Raman, R., Lane, T. R., Perez, J., Farrera, D. O., Wright, S. H., Cherrington, N. J. & Ekins, S., Dec 1 2025, In: Journal of Pharmacology and Experimental Therapeutics. 392, 12, p. 103635 1 p.Research output: Contribution to journal › Article › peer-review
1 Link opens in a new tab Scopus citations -
ToxPoint: The case for Equilibrative Nucleoside Transporters in current regulatory guidance
Martinez-Guerrero, L., Tang, X., Ekins, S., Wright, S. H. & Cherrington, N. J., Nov 1 2025, In: Toxicological Sciences. 208, 1, p. 38-39 2 p.Research output: Contribution to journal › Article › peer-review
Open Access